Adamantylaminoethyl chlorophenoxyacetate
What is it?
The aminoethyl ester hydrochloride named in SU1771186A1. This patent lead is distinct from ADK-957 and from the benzamide compounds.
Research context
The aminoethyl ester hydrochloride named in SU1771186A1. This patent lead is distinct from ADK-957 and from the benzamide compounds.
What the studies found
No study findings are ready to summarize for this preparation. Linked archival leads still need original-source verification; this is not evidence that no research exists.
- Working classification
- Experimental adamantane / analogue
- Research collection
- Actoprotection & occupational pharmacology · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —No human efficacy findings verified in this update
- Study methods
- —Source-specific animal, chemistry, patent or dissertation evidence
- Independent replication
- —Independent replication not established; translations are not separate experiments
- Source access
- —Access and review depth appear with each linked record
- Safety evidence
- —Human safety and interactions not established; animal activity is not a safe-use recommendation
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Chlodantane, Cyclontane and the ADK research programme ↗
Linked sources
Explore the research map and unresolved leads ↗
Para-chlorophenoxyacetic acid adamant-2-ylaminoethyl ester hydrochloride with claimed thermoprotective and psychostimulant activities
N. V. Klimova, T. D. Karpova, Sh. Karadzhaev, N. P. Bykov, N. I. Avdyunina, B. M. Pyatin, I. S. Morozov, G. V. Pushkar, I. M. Zinovyeva · SU1771186A1; filed 23 October 1990; published 10 November 1995
The patent identifies a distinct aminoethyl ester and claims thermoprotective and psychostimulant activity. It is not ADK-957’s amide and is not Chlodantane.
- Population / setting
- Patent-described experimental compound
- What was checked
- Patent identity, title, inventors and dates checked; quantitative pharmacology not appraised.
Limitations & review scope
- Patent claims are not verified clinical findings; experimental magnitude and independent replication remain unassessed.
Source checked 2026-10-03. This is a source-linked record, not a completed evidence review.